Biotech and biopharma regulatory pathway classification: FDA, EMA, agricultural and gene therapy pathwaysNorth American Industry Classification System 2022
Biotechnology Regulatory Pathway Types to NAICS 2022 Crosswalk
Full concordance from Biotech and biopharma regulatory pathway classification: FDA, EMA, agricultural and gene therapy pathways to North American Industry Classification System 2022. 8 official equivalence edges. Pick a sector below to see its mapping, or use the interactive crosswalk explorer for full-tree drill-down.
Biotechnology Regulatory Pathway Types sectors mapped to NAICS 2022
- dbtreg_advancedAdvanced Therapy Regulatory FrameworksBiotechnology Regulatory Pathway Types dbtreg_advanced to NAICS 2022 mapping
- dbtreg_agbioAgricultural Biotechnology Regulatory PathwaysBiotechnology Regulatory Pathway Types dbtreg_agbio to NAICS 2022 mapping
- dbtreg_emaEuropean Medicines Agency (EMA) PathwaysBiotechnology Regulatory Pathway Types dbtreg_ema to NAICS 2022 mapping
- dbtreg_fdaUS FDA Regulatory PathwaysBiotechnology Regulatory Pathway Types dbtreg_fda to NAICS 2022 mapping